Business Leader Tempus

Tempus Massive Contribution in Precision Medicine Under Eric Lefkofsky Leadership

Eric Lefkofsky is an American entrepreneur and philanthropist. He is popularly known for his active participation in medicine, particularly when he started a medical start-up company known as Tempus in 2015. For the last seven years, Eric Lefkofsky has served as CEO at Tempus. This company incorporates artificial intelligence and machine learning technologies to improve the lives of patients who have cancer and other diseases.

 

Under Mr. Lefkofsky’s leadership, Tempus has played a vital role in the field of medicine, particularly in precision medicine. By investing in precision medicine, Tempus has taken specific and successful approaches in finding treatments for patients by considering their genetic, environmental, and lifestyle factors. As a technological-based, innovative company led by Eric Lefkofsky, Tempus analyses both clinical and molecular data to develop precise methods that would help treat patients with cancer and other diseases. 

 

Tempus CEO, Eric LefKofsky, has vast experience in the entrepreneurship field, having founded and led multiple companies. Most technological-based including, Mediaocean, InnerWorkings, Lightworks, etc. Apart from being an entrepreneur, Eric LefKofsky is also a mentor, sharing most of his knowledge with young entrepreneurs at the University of Chicago Booth School of Business. 

In addition, Mr. Lefkofsky is also an excellent writer, having written and published a book known as Accelerated Disruption. Tempus has received a substantial amount of money in the recent past from stakeholders and investors. Currently, Eric Lefkofsky points out, Tempus is worth more than 3.1 billion dollars and offers extensive services such as the Tempus Integrated Molecular Evaluation Trial program, which has increased the number of patients participating in clinical trials.